Últimas noticias sobre Kairos Pharma (AMEX:KAPA) Bolsa

Kairos Pharma

Kairos Pharma Ltd is a clinical-stage biopharmaceutical company. It is engaged in therapeutics for cancer patients that are designed to overcome key hurdles in immune suppression and drug resistance. These therapeutics include antibodies and small molecules for the treatment of prostate cancer, lung cancer, breast cancer, and glioblastoma.

Kairos Pharma Ltd

WIIM

TIVC

Tivic Health Systems shares are trading lower after the company reported a year-over-year decline in Q3 sales results.

D. Boral Capital analyst Jason Kolbert maintains Quince Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNCX#NASDAQ">QNCX</a>) with a Buy and maintains $12 price target.

News

Price Target

Analyst Ratings

QNCX

D. Boral Capital Maintains Buy on Quince Therapeutics, Maintains $12 Price Target

Earnings

OCTO

Eightco Holdings Q3 Sales $7.7M Down From $23.3M YoY

Traws Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRAW#NASDAQ">TRAW</a>) reported quarterly losses of $(8.81) per share which missed the analyst consensus estimate of $(6.12) by 43.95 percent. The company reported quarterly sales of $57.000 million which beat the analyst consensus estimate of $58.000 thousand by 98.18K percent.

Earnings Beats

Earnings Misses

TRAW

Traws Pharma Q3 2024 GAAP EPS $(8.81) Misses $(6.12) Estimate, Sales $57.000M Beat $58.000K Estimate

Trading Ideas

GOOGL

UBER

Third Point 13F Shows Exited Position In Alphabet, Previously Holding 1,980,000 Shares; American Intl Group, Previously Holding 3,450,000 Shares; Verizon Communications, Previously Holding 4,675,000 Shares; Uber Technologies Inc, Previously Holding 2,100,000 Shares; KB Home, Previously Holding 2,100,000 Shares

Billionaire investor Warren Buffett cut several of Berkshire Hathaway Inc&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) <a href="https://www.benzinga.com/markets/equities/24/08/40232279/is-warren-buffett-bearish-or-waiting-to-pounce-berkshire-now-owns-more-t-bills-than-federal-rese">largest holdings this year</a>. 
The Omaha, Nebraska-based holding company&#8217;s latest 13F filing shows that the sell-off trend continues.
What Happened: Berkshire&#8217;s latest 13F filing, filed on Thursday, reflects the company&#8217;s largest holdings as of September 30.
Buffett reduced his stake in Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) from 400 million to 300 million shares. Thus, Berkshire has now cut its position in the Cupertino, California-based tech giant by over two-thirds since 2023&#8217;s third quarter.
The Omaha &#8220;oracle&#8221; also continued to cut his stake in Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>), trimming back another 23% of Berkshire&#8217;s position.
Berkshire cut nearly all of its position in Ulta Beauty Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ULTA#NASDAQ">ULTA</a>). Buffett <a href="https://www.benzinga.com/markets/equities/24/08/40385824/warren-buffett-still-holds-400m-apple-shares-reveals-new-investments-in-ulta-beauty-and-heico-el">revealed a position in the cosmetic store chain</a> in August; the company&#8217;s stock has performed roughly even since then. Buffett&#8217;s Ulta holding period was unusually short for the famed value investor.
Meanwhile, Buffett added a couple of fresh faces to Berkshire&#8217;s portfolio.
Buffett bought 1,277,256 shares of Ann Arbor, Michigan-based pizza chain Domino&#8217;s Pizza Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPZ#NYSE">DPZ</a>). He also made a foray into pool equipment, buying 404,057 shares of Pool Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POOL#NASDAQ">POOL</a>).
Price Action: Investors quickly reacted to Berkshire&#8217;s 13F filing after hours:
<ul>
<li>Dominoes Pizza shares traded up nearly 7%.</li>
<li>Pool Corp shares traded up nearly 6%.</li>
<li>Ulta Beauty shares fell over 4%.</li>
<li>Apple and Bank of America shed insignificant portions of their market value.</li>
</ul>
Why it Matters: During Berkshire&#8217;s annual shareholder meeting in May, Buffett hinted that his sell-offs were a result of tax implications. 
This <a href="https://www.benzinga.com/markets/equities/24/08/40385824/warren-buffett-still-holds-400m-apple-shares-reveals-new-investments-in-ulta-beauty-and-heico-el">has not stopped</a> investors&#8217; conjecture that Buffett is perhaps bearish <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">on the market at large</a>.
Alternatively, Buffett could be simply trimming positions that take up an outsized portion of Berkshire&#8217;s portfolio to reduce exposure.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41988194/trump-plans-to-erase-ev-tax-credit-analyst-says-its-net-bullish-calls-sell-off-wrong-knee-jerk-reaction">Trump Plans To Erase EV Tax Credit: Tesla Analyst Says It&#8217;s &#8216;Net Bullish,&#8217; Calls Sell-Off &#8216;Wrong Knee-Jerk Reaction&#8217;</a></li>
</ul>
Image via Flickr

Equities

AAPL

POOL

ULTA

Warren Buffett's Berkshire Hathaway Slashes Apple, BofA Holdings, Adds Domino's Pizza In Q3

LGCY

Legacy Education shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

Benitec Biopharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNTC#NASDAQ">BNTC</a>) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.55) by 12.73 percent.

BNTC

Benitec Biopharma Q1 2025 GAAP EPS $(0.48) Beats $(0.55) Estimate

MLSS

Milestone Scientific shares are trading higher after the company reported better-than-expected Q3 financials.

Hedge Funds

General

MRCY

Starboard Value's Q3 2024 13F Filing Reveals Complete Exits From Mercury Systems With 2.29M Shares, AECOM With 625K Shares

BENF

Beneficient shares are trading higher after the company reported a year-over-year increase in Q2 revenue results.

OPTX

Syntec Optics Holdings Q3 EPS $0.00 Down From $0.01 YoY, Sales $7.86M Up From $6.6M YoY

Billionaire investor Chase Coleman's hedge fund, Tiger Global Management, filed its latest <a href="https://www.sec.gov/Archives/edgar/data/1167483/000091957424006690/xslForm13F_X02/infotable.xml">Form 13F</a> on Thursday and disclosed its trading activity from the prior quarter. Here's a look at Tiger Global's <a href="https://www.benzinga.com/opinion/24/08/40422936/steal-these-two-stock-ideas-from-the-best-investors-in-the-world">portfolio changes.&nbsp;</a>
The Details: Tiger Global has $23.439 billion in assets under management and made no changes to its top five holdings:&nbsp;
<ul>
<li>Meta Platforms, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) </li>
<li>Microsoft Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) </li>
<li>Alphabet, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) </li>
<li>Apollo Global Management, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APO#NYSE">APO</a>) </li>
<li>Sea Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SE#NYSE">SE</a>) </li>
</ul>
Read Next: <a href="https://www.benzinga.com/trading-ideas/movers/24/11/41949068/bitcoin-could-reach-1-million-by-2037-economist-says-buy-of-a-lifetime-opportunity">Bitcoin Could Reach $1 Million By 2037, Economist Says: &#8216;Buy Of A Lifetime&#8217; Opportunity</a>
New Positions: Tiger Global opened three new positions including a $801.3 million stake in Flutter Entertainment Plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FLUT#NYSE">FLUT</a>), the parent company of FanDuel. The fund also opened a $201.4 million position in Sherwin-Williams Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) and a $48.9 million position in South Korean e-commerce platform Coupang, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CPNG#NYSE">CPNG</a>). 
Notable Trades: Tiger Global added 564,090 shares of Taiwan Semiconductor Manufacturing Company Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) to its portfolio, bringing its total number of shares owned to 3,634,980. The fund also increased its stake in Take-Two Interactive Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) by 195,714 shares, bringing its current holdings to 5,839,256 shares valued at $897.5 million. 
Closed Positions: The hedge fund closed out its positions in Astera Labs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALAB#NASDAQ">ALAB</a>) and DexCom, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DXCM#NASDAQ">DXCM</a>) 
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/biotech/24/11/41822473/trumps-potential-health-czar-robert-f-kennedy-jr-rattles-vaccine-stocks-shoot-first-reaction">Trump&#8217;s Potential &#8216;Health Czar&#8217; Robert F. Kennedy Jr. Rattles Vaccine Stocks: &#8216;Shoot First Reaction&#8217;</a></li>
</ul>
Image created using artificial intelligence via MidJourney.

Movers

ALAB

CPNG

DXCM

FLUT

MSFT

TTWO

Tiger Global Hedge Fund Buys Flutter Entertainment Stock, Sells DexCom

RVYL

Ryvyl shares are trading lower after the company reported worse-than-expected Q3 financial results and cut its FY24 sales guidance.

BLMN

GDDY

Starboard Value's Q3 2024 13F Filing Shows Reduced Stakes In GoDaddy By 32% To 3.13M Shares, Salesforce By 14% To 1.44M Shares, Humana By 62% To 191K Shares, And Bloomin' Brands By 14%

AMZN

Third Point 13F Shows Decreased Stake In PG&E Corp By 7% From 53,750,000 To 49,750,000 Shares; Amazon By 27% From 5,100,000 To 3,700,000 Shares; Danaher Corp By 5% From 2,050,000 To 1,950,000 Shares; Vistra Corp By 29% From 4,470,000 To 3,175,000 Shares; Microsoft By 45% From 1,580,000 To 870,000 Shares; Meta Platforms By 50% From 1,100,000  To 545,000 Shares; TSM By 12% From 2,025,000 To 1,780,000 Shares; Apple By 52% From 1,950,000 To 930,000 Shares; Amphenol Corp By 43% From 2,800,000 To 1,600,000 Shares

AISP

Airship AI shares are trading lower after the company reported worse-than-expected Q3 revenue results.

ADSK

MTCH

Starboard Value's Q3 2024 13F Filing Reveals New Stakes In Autodesk With 1.85M Shares, Match Group With 9.56M Shares

SEC Chairman Gary Gensler on Thursday defended his regulatory approach to crypto markets, emphasizing investor protection and compliance, as he hinted at an end of his stint as <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41883348/donald-trump-cant-fire-gary-gensler-but-pro-crypto-policies-means-industry-is-on-the-verge-of-a-golden-era">the agency&#8217;s chair</a>.
What Happened: In his remarks at the Practicing Law Institute&#8217;s 56th Annual Institute on Securities Regulation, Gensler <a href="https://www.sec.gov/newsroom/speeches-statements/gensler-remarks-pli-s-56th-annual-institute-securities-regulation-111424">noted</a> that his agenda builds on the SEC's history of oversight in crypto, referencing cases like Ripple (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), and emphasized the consistency of the Commission's actions over the years.
He said that since 2018, around 5-7% of SEC enforcement has been directed toward digital assets, maintaining that the agency&#8217;s approach targets specific non-compliant participants rather than the entire crypto market. 
He affirmed that "court after court" has upheld the SEC's jurisdiction over offerings that involve securities, even in digital forms.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41985685/investor-loses-25m-due-to-misplaced-crypto-transfer-says-cexs-feel-more-secure">Investor Loses $25M Due To Misplaced Crypto Transfer, Says CEXs Feel More Secure</a>
"Everything we've done is focused on ensuring compliance with our laws," Gensler said. 
He added that investor protection, through disclosure and oversight, has been a central priority, adding that compliance fosters market trust. 
Highlighting the SEC's endorsement of Bitcoin futures ETFs in 2021 and later Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) and Ether (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) products, Gensler claimed these regulated products provided benefits such as lower fees and enhanced transparency, distinguishing them from the broader crypto markets.
His also noted that while Bitcoin, Ether, and stablecoins comprise a large portion of the crypto market, other assets—often speculative—had yet to demonstrate enduring use cases.
Gensler closed with thanking the team at the Securities and Exchange Commission, emphasizing it has been a &#8220;great honor to serve with them, doing the people's work and ensuring that our capital markets remain the best in the world.&#8221;
What&#8217;s Next: As Gensler&#8217;s term draws to a close, his approach remains influential. His remarks come as the digital asset community gathers insights at events like Benzinga's <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> conference on Nov. 19, where regulatory and innovation discussions continue to unfold.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41984505/bitcoin-to-peak-at-180000-says-vanecks-head-of-digital-assets-research">Bitcoin To Peak At $180,000, Says VanEck&#8217;s Head Of Digital Assets Research</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

$ETH

$XRP

Gary Gensler Hints At Ending His Stint As SEC Chair, Defends Crypto Regulation Agenda

ONCT

Oncternal Therapeutics Announced Workforce Reduction Effective December 2, 2024; Four Employees Will Remain In A Part-time Capacity In Connection With Exploration Of Strategic Alternatives; Expects $2.4M In Charges From Workforce Reduction

Kairos Pharma sets terms for $6M proposed IPO

IPO roundup: NVL, TEM, and more

Wall Street Breakfast: The Week Ahead

IPO Roundup: Bicara Therapeutics, Kairos Pharma and more

Kairos Pharma prices $6.2M IPO

U.S. IPO Weekly Recap: 2 Microcaps List As Pipeline Gets A Big Boost

ADBE

ADMA

ALMS

BCAX

BIOA

BRTH

CBUS

CGON

CIIT

CJOY

CRMT

CUPR

CUTR

DLTR

DRDBU

EBAY

EHGO

ELOG

EMPG

EQVU

FBGL

FLAI

GLXG

GRDN

GTHX

INHD

IREN

KAPA

KROS

KYTX

LBRJ

MANU

MAXN

MIMI

MOOV

NVRI

ORCL

PATH

PLAY

PSTG

PTLE

QGEN

RBRK

RDACU

SVCO

TELO

TRUP

TSX:MKR

UEOP

WKME

YMAT

ZBIO

ZSPC

IPOs

Press Releases

Kairos Pharma Prices $6.2 Million Initial Public Offering

Kairos Pharma Closing of $6.2 Million Initial Public Offering

Health Care

Kairos Pharma Enters Agreement with PreCheck Health Services to Develop Biomarkers to Identify Patients Responsive to ENV105 to Target Cancer Drug Resistance in Prostate and Lung Cancer Patients

Kairos Pharma to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit

Kairos Pharma (NYSEAmerican: KAPA): Advancing New Strategies to Overcome Cancer Treatment Challenges

Comments

Kairos Pharma

Noticias

Últimas noticias sobre Kairos Pharma (AMEX:KAPA) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL